QualityStocks

[QualityStocks]

QualityStocksNewsBreaks – Earth Science Tech, Inc. (ETST) Announces Partnership for Laboratory Services Related to Hygee Medical Device

Biotechnology company Earth Science Tech, Inc. (OTCQB: ETST) this morning announced its entry into an agreement with Groupe Opmedic Inc. and its Procrea Fertility Laboratories to provide the laboratory services for the detection of sexually transmitted infections (STIs) in women using Hygee, ETST’s proprietary self-sampling medical device. Procrea Fertility offers an advanced range of laboratory testing of cervical cells, including tests for human papillomavirus (HPV), chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). Per the update, the cervical cell samples collected using Hygee are only certified for CT testing, with NG certification expected to follow shortly. “We are excited to be working with partner that has the same vision as we do,” Dr. Michel Aubé, CEO and CSO of ETST, stated in the news release. “We are concerned for the health of all women and the babies they carry when pregnant. The CT test is so essential for infant’s health that the World Health Organization (WHO) encourages all sexually active women between the ages of 15 and 25 to be tested once a year.”

To view the full press release, visit http://ibn.fm/NkuIg

About Earth Science Tech, Inc.

Earth Science Tech, Inc. offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market. There are positive results in studies on breast cancer and immune cells through the University of Central Oklahoma; in addition to studies through DV Biologics that prove the Company’s CBD oil formulation lowers cortisol and functions as a neuro-protectant, with positive result case studies through key health organizations. ETST formulates, markets and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD on the market. For more information, visit the company’s website at www.EarthScienceTech.com